Health In Tech, Inc. has made a significant amendment to its equity incentive plan, increasing the number of shares authorized for issuance. This change comes just ahead of the company's annual stockholder meeting scheduled for November 10, 2026, and reflects the company's strategy to enhance its compensation offerings.

The amendment was approved by the Board of Directors on October 27, 2026, and raises the total number of shares of Class A Common Stock authorized for issuance under the Health In Tech, Inc. Equity Incentive Plan (2024) from 10,677,849 shares to 30,677,849 shares. This change replaces the previously proposed increase to 20,677,849 shares, indicating a more aggressive approach to incentivizing employees and attracting talent.

Background

Health In Tech, Inc. is classified under the SIC code 6411, which pertains to Insurance Agents, Brokers & Service. The company is listed on the Nasdaq under the ticker HIT. Recent filings include a definitive proxy statement filed on October 13, 2026, and an 8-K filing on October 26, 2026, detailing various corporate actions.

What the Filing Says

The recent filing states, "On October 27, 2026, the Board of Directors of the Company approved a revision to Proposal Four to further increase the total number of shares of Class A Common Stock authorized for issuance pursuant to awards granted under the Health In Tech, Inc. Equity Incentive Plan (2024)." This amendment is seen as a strategic move to enhance the company's ability to attract and retain skilled professionals in a competitive market.

Impact

This amendment may affect various stakeholders, including current and prospective employees who will benefit from enhanced equity compensation opportunities. Additionally, it may influence investor sentiment as the company demonstrates its commitment to growth and talent acquisition. Competitors in the insurance sector will likely monitor this development closely, as it could inspire similar adjustments in their own compensation structures.

What's Next

The upcoming annual stockholder meeting on November 10, 2026, will provide a platform for stockholders to vote on the amended proposal and other business matters. The record date for the meeting remains September 18, 2026, and all previously submitted proxies will be disregarded, requiring stockholders to submit new votes using an updated proxy card.